Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma-Reference-Cited by-同舟云学术

Frequent overexpression of CADM1/IGSF4 in lung adenocarcinoma

Published:2009-06 Issue:4 Volume:383 Page:480-484
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kitamura Yuka,Kurosawa Gene,Tanaka Miho,Sumitomo Mariko,Muramatsu Chiho,Eguchi Keiko,Akahori Yasushi,Iba Yoshitaka,Tsuda Hiroyuki,Sugiura Mototaka,Hattori Yoshinobu,Kurosawa Yoshikazu

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference22 articles.

1. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc. Natl. Acad. Sci. USA,1992

2. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20;Reff;Blood,1994

3. Monoclonal antibody therapy of cancer;Adams;Nat. Biotechnol.,2005

4. Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic;Kurosawa;Proc. Natl. Acad. Sci. USA,2008

5. Isolation of antigen/antibody complexes through organic solvent (ICOS) method;Akahori;Biochem. Biophys. Res. Commun.,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of anti-human CADM1 monoclonal antibodies as a potential therapy for adult T-cell leukemia/lymphoma;International Journal of Hematology;2020-07-12

2. Isolation of human monoclonal antibodies that bind to two different antigens and are encoded by germline VH and VL genes;Biochemical and Biophysical Research Communications;2018-09

3. CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation;PLOS Pathogens;2018-04-26

4. Classification of 27 Tumor-Associated Antigens by Histochemical Analysis of 36 Freshly Resected Lung Cancer Tissues;International Journal of Molecular Sciences;2016-11-08

5. CADM1 regelates the G1/S transition and represses tumorigenicity through the Rb-E2F pathway in hepatocellular carcinoma;Hepatobiliary & Pancreatic Diseases International;2016-06